Get the app!
Back to Trades

GORDON CARL L

Director10% OwnerCIK 0001282930

Largest Purchase

$20.0M

Electra Therapeutics, Inc. (ETRA)

Sep 23

Profile

Filings
13
Buy transactions
23
Sell transactions
0
Companies
5
Active
2025–2026

Across 13 filings between 2025–2026, GORDON CARL L, Director, 10% Owner, has disclosed $69.9M in transactions — spread across 5 companies. Their disclosed trades are heavily weighted toward buying — $65.5M in buys and $0 in sells. The largest single open-market purchase on record is $20.0M in Electra Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

13 loaded
Nov 10ETRA
Electra Therapeutics, Inc.
GORDON CARL LDirector, 10% OwnerBuy$744.5K
Nov 5ETRA
Electra Therapeutics, Inc.
GORDON CARL LDirector, 10% OwnerBuy$3.6M
Sep 30ADRX
ADARx Pharmaceuticals, Inc.
GORDON CARL LDirector, 10% OwnerBuy$16.1M
Sep 24ADRX
ADARx Pharmaceuticals, Inc.
GORDON CARL LInsiderOther$0
Sep 23ETRA
Electra Therapeutics, Inc.
GORDON CARL LDirector, 10% OwnerBuy$20.0M
Sep 18ETRA
Electra Therapeutics, Inc.
GORDON CARL LInsiderOther$0
Aug 12BLSM
BlossomHill Therapeutics, Inc.
GORDON CARL LDirectorBuy$10.0M
Aug 10BLSM
BlossomHill Therapeutics, Inc.
GORDON CARL LInsiderAward$382.5K
Aug 6BLSM
BlossomHill Therapeutics, Inc.
GORDON CARL LInsiderOther$0
Jul 29SCTX
Scribe Therapeutics, Inc.
GORDON CARL LDirectorBuy$15.0M
Jul 27SCTX
Scribe Therapeutics, Inc.
GORDON CARL LInsiderAward$220.9K
Jul 23SCTX
Scribe Therapeutics, Inc.
GORDON CARL LInsiderOther$0
Dec 18KROS
Keros Therapeutics, Inc.
GORDON CARL LDirectorDisposed$3.8M

13 filings